Evidence map›Paper›PMID 22582173›Full record

ArticleAmerican journal of respiratory cell and molecular biology2012

Calpain inhibition preserves talin and attenuates right heart failure in acute pulmonary hypertension.

Hasan A Ahmad, Li Lu, Shuyu Ye, Gregory G Schwartz, Clifford R Greyson

Abstract read
In one paragraph

Article in American journal of respiratory cell and molecular biology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.6field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Targeting JP2: A New Treatment for Pulmonary Hypertension.Oxidative medicine and cellular longevity · 2021
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. The NO/ONOO-cycle as the central cause of heart failure.International journal of molecular sciences · 2013
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Hasan A AhmadCardiology Section, Veterans Affairs Medical Center, 1055 Clermont Street, Cardiology 111B, Denver, CO 80220, USA. Clifford.Greyson@UCDenver.edu
Li Lu
Shuyu Ye
Gregory G Schwartz
Clifford R Greyson
University of Colorado Denver · USVeterans Health Administration · US

Funding

Protection by Thiazolidinediones in Myocardial IschemiaR01HL049944 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI SCHWARTZ, GREGORY G · 1994 to 2013
$3.7M
Right Ventricular Dysfunction After Pressure OverloadR01HL068606 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI GREYSON, CLIFFORD RUSSELL · 2003 to 2006
$1.2M
Calpain Activation and Inhibition in Right Heart FailureF32HL076072 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI AHMAD, HASAN A · 2005 to 2006
$118k
Right ventricular contractile dysfunction after pressure overloadI01BX001003 · VA · VA EASTERN COLORADO HEALTH CARE SYSTEM · PI GREYSON, CLIFFORD RUSSELL · 2013 to 2016
–
BLRD VA I01 BX001003NHLBI NIH HHS F32 HL076072NHLBI NIH HHS HL076072NHLBI NIH HHS HL49444NHLBI NIH HHS HL68606NHLBI NIH HHS R01 HL049944NHLBI NIH HHS R01 HL068606
6 · The paper itself

Abstract

Right heart failure from right ventricular (RV) pressure overload is a major cause of morbidity and mortality, but its mechanism is incompletely understood. We tested the hypothesis that right heart failure during 4 hours of RV pressure overload is associated with alterations of the focal adhesion protein talin, and that the inhibition of calpain attenuates RV dysfunction and preserves RV talin. Anesthetized open-chest pigs treated with the calpain inhibitor MDL-28170 (n = 20) or inactive vehicle (n = 23) underwent 4 hours of RV pressure overload by pulmonary artery constriction (initial RV systolic pressure, 64 ± 1 and 66 ± 1 mm Hg in MDL-28170 and vehicle-treated pigs, respectively). Progressive RV contractile dysfunction was attenuated by MDL-28170: after 4 hours of RV pressure overload, RV systolic pressure was 44 ± 4 mm Hg versus 49 ± 6 mm Hg (P = 0.011), and RV stroke work was 72 ± 5% of baseline versus 90 ± 5% of baseline, (P = 0.027), in vehicle-treated versus MDL-28170-treated pigs, respectively. MDL-28170 reduced the incidence of hemodynamic instability (death or systolic blood pressure of < 85 mm Hg) by 46% (P = 0.013). RV pressure overload disrupted talin organization. MDL-28170 preserved talin abundance in the RV free wall (P = 0.039), and talin abundance correlated with the maintenance of RV free wall stroke work (r = 0.58, P = 0.0039). α-actinin and vinculin showed similar changes according to immunohistology. Right heart failure from acute RV pressure overload is associated with reduced talin abundance and disrupted talin organization. Calpain inhibition preserves the abundance and organization of talin and RV function. Calpain inhibition may offer clinical utility in treating acute cor pulmonale.

Indexed as

ActininAcute DiseaseAnimalsCalpainDipeptidesElectrophoresis, Polyacrylamide GelHeart FailureHeart VentriclesHypertension, PulmonarySwineTalinActininCalpaincalpain inhibitor IIIDipeptidesTalin

Identifiers

PMID22582173
PMCPMC3488694
OpenAlexW2024549374

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.